
Drugs giant AstraZeneca has listed on the New York Stock Exchange, as it targets further global growth.
The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.

Drugs giant AstraZeneca has listed on the New York Stock Exchange, as it targets further global growth.
The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.